Brief: Elos Medtech Gets Clearance To Market Elos Accurate Hybrid Base On U.S. Dental Implant Market
19/02/2020 15:22
Feb 19 (Reuters) - Elos Medtech AB ELOSSb.ST :
* HAS RECEIVED FDA 510(K) CLEARANCE TO MARKET ELOS ACCURATE
HYBRID
BASE ON U.S. DENTAL IMPLANT MARKET
Source text for Eikon: ID:nWkr4bXkLZ
Further company coverage: ELOSSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Elos Medtech AB
See all newsBrief: Em Intressenter AB Initiates Compulsory Redemption Proceedings
Brief: Elos Medtech Q3 Operating Profit SEK 31.7 Million
Brief: Elos Medtech Resolves On Rights Issue Worth SEK 4.34 Bln
Brief: Elos Medtech Acquires Klingel Medical Through Guaranteed Rights Issue
Brief: Elos Medtech Q2 Operating Profit at SEK 30.1 Million